Skip to main content
Clinical Trials/NCT05621577
NCT05621577Not yet recruitingNot Applicable

Socio-Demographic - Dental & Respiratory Changes of Obstructive Sleep Apnea (OSA) Patients Treated With Mandibular Advancement Device (MAD) of Samples in Erbil City

Hawler Medical University1 site in 1 country20 target enrollmentStarted: February 5, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
20
Locations
1
Primary Endpoint
measuring polysomnography record changes pre and post using appliance

Study Overview

Brief Summary

The purpose of this study is to evaluate efficacy of mandibular advancement device (MAD). on treating obstructive sleep apneas, symptoms, Apnea/Hypopnea Index (QHI) and the Respiratory Arousal Index (AHI/REI) and peripheral capillary oxygen saturation (SpO2) Range, PULSE in patients with mild to moderate obstructive sleep apnea/hypopnea syndrome, and evaluating potential dental side effects

Detailed Description

The primary oral appliance (OA) used in obstructive sleep apnea (OSA) treatment is the mandibular advancement device (MAD). MADs may be either an over-the-counter stock device or customized for individual patients. MADs come in various designs and materials, but most comprise upper and lower splints mounted over the dentition as either a 1-piece monoblock or a 2-piece biblock Connectors or blocks relate the upper and lower splints in a biblock to protrude the mandible in a forward position during sleep.

Although the efficacy of oral appliances has been proved, the relationship to the nature of airway enlargement in patients with OSA has not yet been clearly demonstrated.

The aim of this study is therefore to evaluate the efficacy mandibular repositioning appliance reduces sleep apneas symptoms with mild to moderate obstructive sleep apnea . Secondary outcomes include the dental side effects of such appliance. At baseline and after 4 month's treatment, This study will be conducted to estimate frequency of OSA on population sample from Erbil study, in addition trying to evaluate the efficiency of MAD on some patients who are diagnosed with OSA.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
25 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •sample will be taken from Kurdish population in Erbil city.
  • •Obstructive sleep apnea, apnea-hypopnea index of <30 with excessive daytime sleepiness

Exclusion Criteria

  • •People with problems in nasal part of airway.
  • •People with cleft lip and palate
  • •Patient who did tonsillectomy and / or other pharyngeal operations.
  • •People who take any kind of sleep medication.
  • •Temporomandibular Disorders.
  • •People with periodontal disease.
  • •Less than 8 teeth/ arch.

Arms & Interventions

mandibular advancing device

Other

using mandibular advancement device for treatment of obstructive sleep apnea

Intervention: MANDIBULAR ADVANCEMENT DEVICE (Device)

Outcomes

Primary Outcomes

measuring polysomnography record changes pre and post using appliance

Time Frame: 6 months

comparing polysomnography readings before and after using MAD to evaluate appliance efficacy

Secondary Outcomes

  • dental side effects(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Haval Jalal Rasheed

assistant lecturer

Hawler Medical University

Study Sites (1)

Loading locations...

Similar Trials